Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A new approach to ticagrelor-based de-escalation of antiplatelet therapy after acute coronary syndrome. A rationale for a randomized, double-blind, placebo-controlled, investigator-initiated, multicenter clinical study.
Kubica J, Adamski P, Niezgoda P, Kubica A, Podhajski P, Barańska M, Umińska JM, Pietrzykowski Ł, Ostrowska M, Siller-Matula JM, Badarienė J, Bartuś S, Budaj A, Dobrzycki S, Fidor Ł, Gąsior M, Gessek J, Gierlotka M, Gil R, Gorący J, Grzelakowski P, Hajdukiewicz T, Jaguszewski M, Janion M, Kasprzak J, Kern A, Klecha A, Kleinrok A, Kochman W, Krakowiak B, Legutko J, Lesiak M, Nosal M, Piotrowski G, Przybylski A, Roleder T, Skonieczny G, Sobieszek G, Tycińska A, Wojciechowski D, Wojakowski W, Wójcik J, Zielińska M, Żurakowski A, Specchia G, Gorog DA, Navarese EP. Kubica J, et al. Among authors: pietrzykowski l. Cardiol J. 2021;28(4):607-614. doi: 10.5603/CJ.a2021.0056. Epub 2021 Jun 7. Cardiol J. 2021. PMID: 34096012 Free PMC article. Clinical Trial.
Influence of METHoxyflurane on ANtiplatelet Effect of ticagrelor in patients with unstable angina pectoris: Rationale and a protocol of a randomized clinical METHANE-SIRIO 4 study.
Niezgoda P, Barańska M, Adamski P, Pietrzykowski Ł, Marszałł MP, Wojakowski W, Kuliczkowski W, Gorog D, Jilma B, Nadolny K, Navarese EP, Kubica A, Kubica J. Niezgoda P, et al. Among authors: pietrzykowski l. Cardiol J. 2022;29(2):324-328. doi: 10.5603/CJ.a2021.0126. Epub 2021 Oct 13. Cardiol J. 2022. PMID: 34642919 Free PMC article. No abstract available.
Ion channel inhibition with amiodarone or verapamil in symptomatic hospitalized nonintensive-care COVID-19 patients: The ReCOVery-SIRIO randomized trial.
Navarese EP, Podhajski P, Andreotti F, La Torre G, Gajda R, Radziwanowski A, Nowicka M, Bukowski P, Gajda J, Omyła M, Lackowski P, Piasecki M, Jasiewicz M, Szymański P, Pietrzykowski Ł, Michalski P, Kubica A, Urbanowicz I, Orsini N, Conte M, Pinkas J, Brouwer MA, Kubica J. Navarese EP, et al. Among authors: pietrzykowski l. Cardiol J. 2022;29(5):739-750. doi: 10.5603/CJ.a2022.0072. Epub 2022 Aug 1. Cardiol J. 2022. PMID: 35912711 Free PMC article. Clinical Trial.
Therapy Discontinuation after Myocardial Infarction.
Pietrzykowski Ł, Kasprzak M, Michalski P, Kosobucka A, Fabiszak T, Kubica A. Pietrzykowski Ł, et al. J Clin Med. 2020 Dec 19;9(12):4109. doi: 10.3390/jcm9124109. J Clin Med. 2020. PMID: 33352811 Free PMC article.
Gender-Related Effectiveness of Personalized Post-COVID-19 Rehabilitation.
Rzepka-Cholasińska A, Ratajczak J, Michalski P, Kasprzak M, Kosobucka-Ozdoba A, Pietrzykowski Ł, Grzelakowska K, Kubica J, Kryś J, Kubica A. Rzepka-Cholasińska A, et al. Among authors: pietrzykowski l. J Clin Med. 2024 Feb 6;13(4):938. doi: 10.3390/jcm13040938. J Clin Med. 2024. PMID: 38398252 Free PMC article.
Achieving Cardiovascular Risk Management Goals and Patient Quality of Life.
Kosobucka-Ozdoba A, Pietrzykowski Ł, Michalski P, Ratajczak J, Grzelakowska K, Kasprzak M, Kubica J, Kubica A. Kosobucka-Ozdoba A, et al. Among authors: pietrzykowski l. J Cardiovasc Dev Dis. 2024 Jan 31;11(2):45. doi: 10.3390/jcdd11020045. J Cardiovasc Dev Dis. 2024. PMID: 38392259 Free PMC article.
14 results